doi: 10.1136/bmj.k3207, 39
Across all GBD regions, a similar disease attribution pattern was observed, with alcohol use disorders, digestive diseases, and cardiovascular conditions accounting for the majority of high alcohol use-attributable DALYs

These retailers continued to receive special price offers and promotional materials.31 After receiving extensive incentives, retailers from around the world were described as vocal allies for tobacco manufacturers.7 15 17 24 37 39 For example, one study discussed that large incentives associated with contracts may lead retailers to lobby for protobacco policy.24 Interestingly, interviews and industry documents from manufacturer representatives highlighted an unexpected, perceived power dynamic that did not match findings from studies with retailers: representatives portrayed retailers as holding power over manufacturers, withholding display space, and demanding larger financial incentives.6 37 39 They used language that described retailer incentives as manufacturer requirements with one representative in Australia reporting, if we werent giving [a retailer] a competitive offer, then they would remove most of our slots,39 and an industry document also from Australia stating, retailers immediately realized they were sitting on a gold mine at retail when printwent away.37 However, that depicted power dynamic does not represent the typical manufacturerretailer relationship

Alcohol withdrawal rates in hospitalized patients during the COVID-19 pandemic